JP2024506602A5 - - Google Patents

Info

Publication number
JP2024506602A5
JP2024506602A5 JP2023547568A JP2023547568A JP2024506602A5 JP 2024506602 A5 JP2024506602 A5 JP 2024506602A5 JP 2023547568 A JP2023547568 A JP 2023547568A JP 2023547568 A JP2023547568 A JP 2023547568A JP 2024506602 A5 JP2024506602 A5 JP 2024506602A5
Authority
JP
Japan
Prior art keywords
composition according
composition
inhibitor
rock2
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023547568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506602A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/015072 external-priority patent/WO2022169946A1/en
Publication of JP2024506602A publication Critical patent/JP2024506602A/ja
Publication of JP2024506602A5 publication Critical patent/JP2024506602A5/ja
Pending legal-status Critical Current

Links

JP2023547568A 2021-02-04 2022-02-03 浮腫および関連状態の処置のための選択的ｒｏｃｋ２阻害 Pending JP2024506602A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163145526P 2021-02-04 2021-02-04
US63/145,526 2021-02-04
US202163209324P 2021-06-10 2021-06-10
US63/209,324 2021-06-10
US202163228404P 2021-08-02 2021-08-02
US63/228,404 2021-08-02
PCT/US2022/015072 WO2022169946A1 (en) 2021-02-04 2022-02-03 Selective rock2 inhibition for treatment of edema and associated conditions

Publications (2)

Publication Number Publication Date
JP2024506602A JP2024506602A (ja) 2024-02-14
JP2024506602A5 true JP2024506602A5 (https=) 2025-02-12

Family

ID=82742517

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547568A Pending JP2024506602A (ja) 2021-02-04 2022-02-03 浮腫および関連状態の処置のための選択的ｒｏｃｋ２阻害

Country Status (4)

Country Link
US (1) US20240131029A1 (https=)
EP (1) EP4288075A4 (https=)
JP (1) JP2024506602A (https=)
WO (1) WO2022169946A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201801226D0 (en) 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase
EP4393917A4 (en) * 2021-09-18 2025-09-10 Beijing Tide Pharmaceutical Co Ltd SOLID FORM OF A RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, METHOD OF PREPARATION AND USE THEREOF
CN117843618A (zh) * 2022-08-29 2024-04-09 北京沐华生物科技有限责任公司 一种ep300/cbp调节剂及其制备方法和用途
WO2026047205A2 (en) * 2024-08-30 2026-03-05 Université de Liège Treatments for lymphedema

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20121126A1 (es) 2006-12-21 2012-08-24 Plexxikon Inc Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
WO2015054654A1 (en) 2013-10-10 2015-04-16 Fibralign Corporation Method and device for lymphedema treatment
EP3262041A4 (en) * 2015-02-27 2018-08-01 Lycera Corporation Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
WO2017044454A1 (en) 2015-09-11 2017-03-16 Propagenix Inc. Ex vivo proliferation of epithelial cells
EP3504204A4 (en) * 2016-08-26 2020-05-27 Lycera Corporation INDAZOLYL-L, 2,4-THIADIAZOLAMINE AND RELATED COMPOUNDS FOR INHIBITING RHO-ASSOCIATED PROTEIN KINASES AND FOR TREATING DISEASES
GB201801226D0 (en) * 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase

Similar Documents

Publication Publication Date Title
JP2024506602A5 (https=)
JP2022008860A5 (https=)
US12458642B2 (en) Metalloenzyme inhibitor compounds
TWI643619B (zh) 一種用於預防或治療青光眼或高眼壓症、或降低眼壓之醫藥組合物及其用途
JP6097888B2 (ja) 新規使用
CN100430056C (zh) Mglur5拮抗剂在制备治疗gerd的药物中的用途
WO2004082715A1 (ja) 炎症性腸疾患治療剤としての併用医薬
RU98119885A (ru) Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность
TW201414471A (zh) 新穎用途
US11919883B2 (en) Metalloenzyme inhibitor compounds
DK3027183T3 (en) SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT
JP2016510785A5 (https=)
AU2022404695B2 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2005527523A5 (https=)
JP2021522246A (ja) 癌治療のための併用
JP2021530488A (ja) 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール
JP2021530440A5 (https=)
KR20200067859A (ko) Ccr3-억제제를 사용한 소양증, 건조증, 및 관련 질환을 치료하기 위한 방법 및 조성물
WO2021091846A1 (en) Treatment of mast cell diseases and eosinophilic disorders
JP2901226B2 (ja) アレルギー性皮膚炎の処置剤
TW201924721A (zh) 包含pi3激酶抑制劑與bcl-2抑制劑的組成物
JPH0653678B2 (ja) アレルギ−性疾患治療剤
JP2004538292A (ja) ナトリウム・カルシウム交換系を阻害する医薬
KR20200142245A (ko) 신규한 인다졸 유도체 화합물 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물
JP7316289B2 (ja) 薬物製剤及びその応用